During the past decade, Marienhospital Gelsenkirchen conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marienhospital Gelsenkirchen" #1 collaborator was "Deutsche Krebshilfe e.V., Bonn (Germany)" with 1 trials as a collaborator and "GI Dynamics" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Marienhospital Gelsenkirchen" are "Diabetes Mellitus" (1 trials), "Lymph Node Metastasis" (1 trials), "Obesity" (1 trials), "Oral Cancer" (1 trials) and "Oropharyngeal Cancer" (1 trials). Many other conditions were trialed in "Marienhospital Gelsenkirchen" in a lesser frequency.

Most popular intervention types in "Marienhospital Gelsenkirchen" are "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Insertion of EndoBarrier for approximately one year" (1 trials) and "Radiation therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Marienhospital Gelsenkirchen" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Marienhospital Gelsenkirchen". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Marienhospital Gelsenkirchen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Marienhospital Gelsenkirchen, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".